NM_001164508.2(NEB):c.18052C>T (p.Leu6018Phe) AND Nemaline myopathy 2
- Germline classification:
- Uncertain significance (1 submission)
- Last evaluated:
- Jul 18, 2022
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV002020078.4
Allele description [Variation Report for NM_001164508.2(NEB):c.18052C>T (p.Leu6018Phe)]
NM_001164508.2(NEB):c.18052C>T (p.Leu6018Phe)
Condition(s)
Assertion and evidence details
Last Updated: Dec 24, 2023